BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31981078)

  • 1. SEOM clinical guidelines for cervical cancer (2019).
    de Juan A; Redondo A; Rubio MJ; García Y; Cueva J; Gaba L; Yubero A; Alarcón J; Maximiano C; Oaknin A
    Clin Transl Oncol; 2020 Feb; 22(2):270-278. PubMed ID: 31981078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEOM guidelines for cervical cancer.
    Oaknin A; Rubio MJ; Redondo A; De Juan A; Cueva Bañuelos JF; Gil-Martin M; Ortega E; Garcia-Arias A; Gonzalez-Martin A; Bover I
    Clin Transl Oncol; 2015 Dec; 17(12):1036-42. PubMed ID: 26650487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEOM guidelines for cervical cancer.
    Oaknin A; Díaz de Corcuera I; Rodríguez-Freixinós V; Rivera F; del Campo JM;
    Clin Transl Oncol; 2012 Jul; 14(7):516-9. PubMed ID: 22721796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and Care of Women With Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.
    Chuang LT; Feldman S; Nakisige C; Temin S; Berek JS
    J Clin Oncol; 2016 Sep; 34(27):3354-5. PubMed ID: 27382101
    [No Abstract]   [Full Text] [Related]  

  • 5. SEOM clinical guideline for secondary prevention (2019).
    Santaballa A; Pinto Á; Balanyà RP; Ramírez Merino N; Martín IR; Grau SS; Fombella JPB; Cano JM; González CH; Bayo J
    Clin Transl Oncol; 2020 Feb; 22(2):187-192. PubMed ID: 32006339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).
    Dómine M; Moran T; Isla D; Martí JL; Sullivan I; Provencio M; Olmedo ME; Ponce S; Blasco A; Cobo M
    Clin Transl Oncol; 2020 Feb; 22(2):245-255. PubMed ID: 32040815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special Focus on Stage IV Cervical Cancer Patients: A Decade Experience.
    Espenel S; Garcia MA; Langrand-Escure J; Vallard A; Trone JC; Rancoule C; Vial N; Moreno-Acosta P; Chauleur C; Boutet C; Peoc Apos H M; Prevot-Bitot N; Guy JB; Magné N
    Oncology; 2019; 97(3):125-134. PubMed ID: 31266037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.
    Monk BJ; Tewari KS; Koh WJ
    J Clin Oncol; 2007 Jul; 25(20):2952-65. PubMed ID: 17617527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations.
    Basta T; Knapp P; Blecharz P; Bodnar L; Gawron I; Babczyk D; Piróg M; Kluz T; Markowska A; Horbaczewska A; Jach R
    PLoS One; 2019; 14(1):e0209901. PubMed ID: 30703105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019).
    Martín-Richard M; Carmona-Bayonas A; Custodio AB; Gallego J; Jiménez-Fonseca P; Reina JJ; Richart P; Rivera F; Alsina M; Sastre J
    Clin Transl Oncol; 2020 Feb; 22(2):236-244. PubMed ID: 31989475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in immunotherapy in cervical cancer.
    Grau JF; Farinas-Madrid L; Garcia-Duran C; Garcia-Illescas D; Oaknin A
    Int J Gynecol Cancer; 2023 Mar; 33(3):403-413. PubMed ID: 36878562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of histological type and staging of cervical cancer as prognostic factors among women treated in the Department of Gynecology and Oncology, Jagiellonian University in the years 2001-2014].
    Basta T; Gawron I; Mirocki K; Babczyk D; Jach R
    Przegl Lek; 2017; 74(1):13-20. PubMed ID: 29693995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seom guidelines for the treatment of gastric cancer 2015.
    Martin-Richard M; Custodio A; García-Girón C; Grávalos C; Gomez C; Jimenez-Fonseca P; Manzano JL; Pericay C; Rivera F; Carrato A
    Clin Transl Oncol; 2015 Dec; 17(12):996-1004. PubMed ID: 26691658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
    de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
    Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.
    Boussios S; Seraj E; Zarkavelis G; Petrakis D; Kollas A; Kafantari A; Assi A; Tatsi K; Pavlidis N; Pentheroudakis G
    Crit Rev Oncol Hematol; 2016 Dec; 108():164-174. PubMed ID: 27931835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The guidelines for diagnostics and treatment of cervical cancer].
    Inciūra A; Juozaityte E
    Medicina (Kaunas); 2004; 40(4):394-403. PubMed ID: 15111756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.
    Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
    Radiother Oncol; 2018 Jun; 127(3):404-416. PubMed ID: 29728273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.
    Tewari KS; Monk BJ
    Semin Oncol; 2009 Apr; 36(2):170-80. PubMed ID: 19332251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.